SERTAD1 抗体 (AA 1-42) (Cy3)
Quick Overview for SERTAD1 抗体 (AA 1-42) (Cy3) (ABIN720014)
抗原
See all SERTAD1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 1-42
-
交叉反应
- 小鼠
-
预测反应
- Human,Rat,Dog,Cow,Pig,Rabbit
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human Sertad1
-
亚型
- IgG
-
-
-
-
应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- SERTAD1 (SERTA Domain Containing 1 (SERTAD1))
-
别名
- Sertad1
-
背景
-
Synonyms: SEI1, TRIP-Br1, SERTA domain-containing protein 1, CDK4-binding protein p34SEI1, SEI-1, Transcriptional regulator interacting with the PHD-bromodomain 1, SERTAD1
Background: Acts at E2F-responsive promoters as coregulator to integrate signals provided by PHD- and/or bromodomain-containing transcription factors. Stimulates E2F1/TFDP1 transcriptional activity. Renders the activity of cyclin D1/CDK4 resistant to the inhibitory effects of CDKN2A/p16INK4A.
-
基因ID
- 29950
-
UniProt
- Q9UHV2
抗原
-